A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2013
10/24/2013	WO2013155888A1 Soybean peptide nutrient solution and preparation method and application thereof
10/24/2013	WO2013155555A1 Peptides for the binding of nucleotide targets
10/24/2013	WO2013098672A3 Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations
10/24/2013	WO2013093720A3 Anti-diabetic compounds
10/24/2013	WO2013091883A3 Selective ligands for the angiotensin ii receptors
10/24/2013	WO2010079063A3 Modulators of the cx3cr1 receptor and therapeutic uses thereof
10/24/2013	WO2003044171A3 Organelle-associated proteins
10/24/2013	WO2002079390A9 $i(pesudomonas) avr and hop proteins, their encoding nucleic acids, and use thereof
10/24/2013	WO2002079385A9 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/24/2013	WO2002061044A9 Synthetic peptide and uses for same
10/24/2013	US20130281517 Cyclopropanecarboxylate esters of purine analogues
10/24/2013	US20130281385 Small molecule apoptosis promoters
10/24/2013	US20130281383 Novel uses of elafin
10/24/2013	US20130281381 Pharmaceutical compositions comprising 8-substituted dibenzylbutyrolactone lignans
10/24/2013	US20130281380 Methods of use of epsilon inhibitor compounds for the attenuation of pain
10/24/2013	US20130281378 Articular Cartilage Mimetics
10/24/2013	US20130281373 Combination therapy
10/24/2013	US20130281372 Methods to enhance rnai oligonucleotide delivery to respiratory epithelial cells
10/24/2013	US20130281370 Angiogenesis promoted by caged growth factors
10/24/2013	US20130281369 Methods for stimulating hair growth
10/24/2013	US20130281367 Agent for Suppressing Elevation of Blood GIP Level, Agent for Suppressing Elevation of Blood Insulin Level, Agent for Lowering Blood Triglyceride Level After Meal Ingestion, and Agent for Suppressing Elevation of Blood Glucose Level
10/24/2013	US20130281364 Preparation Comprising Insulin, Nicotinamide and an Amino Acid
10/24/2013	US20130281362 Antiviral agent
10/24/2013	US20130281361 Methods of treating and preventing rhinovirus infection
10/24/2013	US20130281360 Broad spectrum antibiotic arylomycin analogs
10/24/2013	US20130281358 Peptide
10/24/2013	US20130281357 Anti-angiogenic agent and methods of using such agent
10/24/2013	US20130280760 High purity lipopetides
10/24/2013	US20130280332 Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza Patients
10/24/2013	US20130280311 Methods of reducing skin damage and edema
10/24/2013	US20130280303 Bone delivery system having a therapeutic agent
10/24/2013	US20130280295 Aluminum compounds for use in therapeutics and vaccines
10/24/2013	US20130280251 Stabilized Angiopoietin-2 Antibodies And Uses Thereof
10/24/2013	US20130280247 Regulators of mmp-9 and uses thereof
10/24/2013	US20130280241 15-pgdh in colon cancer
10/24/2013	US20130280236 Factor ii and fibrinogen for treatment of haemostatic disorders
10/24/2013	US20130280235 Methods of diagnosis and treatment for metabolic disorders
10/24/2013	US20130280234 Treatment and Composition for Wound Healing
10/24/2013	US20130280233 Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
10/24/2013	US20130280232 Use of alkaline phosphatase for the detoxification of lps present at mucosal barriers
10/24/2013	US20130280231 Composition for preventing or treating obesity
10/24/2013	US20130280229 Stabilisation of Proteins
10/24/2013	US20130280228 Feed supplement
10/24/2013	US20130280223 Functionalized tissue matrices
10/24/2013	US20130280217 Methods for Use of a Specific Anti-Angiogenic Adenoviral Agent
10/24/2013	US20130280216 Methods for Use of a Specific Anti-Angiogenic Adenoviral Agent
10/24/2013	US20130280214 Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases
10/24/2013	US20130280210 Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase
10/24/2013	US20130280207 Compositions and methods for reducing the risk of spontaneous abortion in a human female
10/24/2013	US20130280205 Activators of SGK-1 for Use as Cardioprotective Agents
10/23/2013	EP2653542A1 Methods and compositions related to mutant kunitz domain I of TFPI-2
10/23/2013	EP2653477A1 Scorpion active peptides and preparation methods and applications thereof
10/23/2013	EP2653168A1 Therapeutic agent for disc herniation
10/23/2013	EP2653167A1 Cell migration modulator
10/23/2013	EP2653166A2 Pharmaceutical composition and related methods
10/23/2013	EP2653156A1 Pharmaceutical emulsion composition and use thereof
10/23/2013	EP2651973A1 Recombinant laminin-521
10/23/2013	EP2651972A1 Novel biomarker and uses thereof in diagnosis, treatment of autism
10/23/2013	EP2651970A1 Serum amyloid p protein
10/23/2013	EP2651965A1 Cyclosporine analogue molecules modified at amino acid 1 and 3
10/23/2013	EP2651964A2 Croos-linked peptides and proteins, methods of making same, and uses thereof
10/23/2013	EP2651963A1 Peptides useful in the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
10/23/2013	EP2651449A2 Chimeric fibronectin matrix mimetics and uses thereof
10/23/2013	EP2651446A1 Preparation comprising insulin, nicotinamide and an amino acid
10/23/2013	EP2651433A1 Aqueous factor viii solution
10/23/2013	EP2651432A1 Fast-acting insulin in combination with long-acting insulin
10/23/2013	EP2651431A2 Method, system and apparatus for control of pancreatic beta cell function to improve glucose homeostatis and insulin production
10/23/2013	EP2651430A1 Biological activity of placental protein 13
10/23/2013	EP2651429A2 Neuropeptide analogs, compositions, and methods for treating pain
10/23/2013	EP2651428A1 Pgc-1alpha-modulating peptides
10/23/2013	EP2651427A1 Novel therapeutic strategies for improving an anticancer treatment
10/23/2013	EP2651426A2 Proteins that stimulate the secretion of satiety hormones
10/23/2013	EP2651414A1 Combination therapy comprising vemurafenib and an interferon for use in the treatment of cancer
10/23/2013	EP2651398A1 Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
10/23/2013	EP2651396A2 Pharmaceutical compositions
10/23/2013	EP2651394A1 Nanoparticles comprising at least one active agent and at least two polyelectrolytes
10/23/2013	CN103370340A Fusion peptide comprising dhFas-1 domain and MMP substrate and use thereof for preventing and treating rheumatoid arthritis
10/23/2013	CN103370339A Multimeric il-15 soluble fusion molecules and methods of making and using same
10/23/2013	CN103370338A Myomegalin variant 8 and uses thereof
10/23/2013	CN103370334A Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof and method for preparing same
10/23/2013	CN103370075A Long-acting IL-1 receptor antagonists
10/23/2013	CN103370074A Sense-improving agent
10/23/2013	CN103370066A Combination therapy comprising vemurafenib and an interferon for use in the treatment of cancer
10/23/2013	CN103370059A A drug delivery device
10/23/2013	CN103370057A Method for removing residual organic solvent from microparticles
10/23/2013	CN103370052A Nanoparticles comprising at least one active agent and at least two polyelectrolytes
10/23/2013	CN103361356A Marsupenaeus japonicus thymulin genes, and preparation method and applications of marsupenaeus japonicus thymulins
10/23/2013	CN103361341A Genetic engineering expression and preparation methods of cecropin LL-37 and application thereof
10/23/2013	CN103361328A Mediated integration HIV-1 (Human Immunodeficiency Virus-1) provirus gene knockout zinc finger nuclease as well as preparation method and application thereof
10/23/2013	CN103360497A Novel antitumor fusion protein vaccine, and preparation method and application thereof
10/23/2013	CN103360486A Antimicrobial peptides comprising arginine-and/or lysine-containing motif
10/23/2013	CN103360485A Antimicrobial peptides comprising an arginine-and/or lysine-containing motif
10/23/2013	CN103360469A 抗微生物多肽 Antimicrobial peptides
10/23/2013	CN103360466A Composition of tumour-associated peptides and related anti-cancer vaccine
10/23/2013	CN103360464A Polypeptide, DNA molecule encoding polypeptide, vector, preparation method and application thereof
10/23/2013	CN103357017A Application of met-RANTES in preparing medicine used for treating inherited retinal degeneration
10/23/2013	CN103357009A Application of Hemokinin-1 in preparation of vaccine adjuvant
10/23/2013	CN103357000A Progressive stroke retardant
10/23/2013	CN103356999A Novel marine organism washing-free disinfection solution and its application
10/23/2013	CN103356998A Composition for treating human white hair and/or leucoderma and application thereof

1 ... 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 ... 3163